NASDAQ
-$1.20
(-1.52%)
Subscribe to get
AI Score
Rockefeller Capital Management L.P. reduced its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 86.7% in the third quarter, according to its most recent filing with the Securities ...
Dexcom Inc (NASDAQ:DXCM) price is hovering higher on current market day and jumping 1.19% above its previous close. A look at today’s price movement shows that the recent level at last check ...
But more than that, you probably want to see it rise more than the market average. Unfortunately for...
Medical device specialist DexCom (NASDAQ: DXCM) is going through a rough patch. The company's shares...
Dexcom (DXCM) , a leader in continuous glucose monitoring (CGM) systems, has positioned itself as a...
Put simply, these types of businesses are compounding machines, meaning they are continually...
Johnson Fistel, LLP investigates potential violations of federal and state laws by certain officers of several publicly traded companies, including DexCom, Inc. (DXCM), Spire Global, Inc. (NYSE ...
On December 3, 2024, Johnson Fistel, LLP announced an investigation into potential violations of federal and state laws by DexCom Inc (DXCM, Financial) and other companies. The investigation ...
Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while...
Free Report) . Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important ...